Extension Study of Intermittent Bilateral GDNF for Parkinsons Disease

• Research type

  Research Study

• Full title

  An Extension Study to Assess the Safety and Efficacy of Intermittent Bilateral Intraputamenal Glial Cell Line-Derived Neurotrophic factor (GDNF) Infusions Administered via Convection Enhanced Delivery (CED) in Subjects with Parkinson's Disease

• IRAS ID

  131299

• Contact name

  Alan Whone

• Contact email

  alan.whone@btinternet.com

• Sponsor organisation

  North Bristol NHS Trust

• Eudract number

  2013-001881-40

• REC name

  South West - Central Bristol Research Ethics Committee

• REC reference

  13/SW/0181

• Date of REC Opinion

  9 Aug 2013

• REC opinion

  Favourable Opinion